Tender ABM/2026/1 for the development of generics and biosimilars

Listed on GrantGunner. Last checked 13 Aug 2026.

About this grant

The Medical Research Agency has announced a competition for the development and advancement of solutions concerning generic and biosimilar drugs, including new pharmaceutical forms and modified release. The goal is to support R&D work leading to commercialization within a maximum of 5 years after the project's completion, strengthening Poland's drug security. Projects may include a commercial clinical trial or one combined with a preclinical study.

Who can apply

Enterprises independently or as consortium leaders; consortia with other enterprises, scientific entities (universities, institutes), and medical entities (healthcare providers) are allowed.

Browse all open grants

More grants from Medical Research Agency